TITLE

Pricing on Amneal Pharma Loan Tightens

AUTHOR(S)
Iyer, Gayatri
PUB. DATE
December 2010
SOURCE
High Yield Report;12/20/2010, Vol. 21 Issue 51, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that pricing on the 155-million U.S. dollars term loan of Amneal Pharmaceutical has tightened to Libor plus 450 basis points (bps).
ACCESSION #
56566123

 

Related Articles

  • Amneal Launches $735M Repricing. Fest, Glen // High Yield Report;6/17/2015, p5 

    The article reports that generic drug producer Amneal Pharmaceuticals is in talks with lenders about a repricing effort for a 735 million U.S. dollars term loan B.

  • GE Markets $155M Pharmaceutical TL. Kellerhals, Richard // High Yield Report;11/22/2010, Vol. 21 Issue 47, p3 

    The article reports on the 155 million U.S. dollar term loan B being marketed by GE Capital for Amneal Pharmaceuticals, a generic drug maker.

  • Amneal DC Set To Be Enlarged.  // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p233 

    The article reports on the plan of Amneal Pharmaceuticals LLC to expand its sales and distribution center in south central in Glasgow, Kentucky.

  • Amneal Unveils Facility in Ky.  // Chain Drug Review;10/25/2010, Vol. 32 Issue 18, p77 

    The article reports on the move of Amneal Pharmaceuticals LLC in opening an expanded distribution and sales operations center in the Kentucky community.

  • Generic Felbamate Now Available from Amneal.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p481 

    The article discusses the release of the generic Felbamate tablets from Amneal Pharmaceuticals LLC.

  • Product Pipeline Continues to Give Patients More Options.  // Chain Drug Review;8/10/2015, Vol. 37 Issue 12, p75 

    The article reports on the options given by pharmaceutical firm Amneal Pharmaceuticals LLC related to generic drug selections in New York.

  • Banks Set Price Talk on Exopack TL. Iyer, Gayatri // High Yield Report;5/23/2011, Vol. 22 Issue 21, p3 

    The article reports that the price for the 400 million U.S. dollars covenant-like term loan of Exopack has been set with a 1.5 percent London Interbank Offered Rate (LIBOR) in May 2011.

  • eResearch Widens Talk on $220M TL. Clouse, Carol J. // High Yield Report;7/2/2012, p7 

    The article reports that eResearch Technology sweetened the terms on its 270-million-dollar credit facility, increasing 220-million-dollars of the term loan to London Interbank Offered Rate (Libor) plus 650 basis points, to boost funding for its acquisition by Genstar Capital.

  • GE Talks Price on Amneal Pharma Term Loan. Bisbey, Allison // High Yield Report;10/14/2013, p11 

    The article reports that Amneal Pharmaceuticals is seeking 475 million dollars of loan to refinance its debt and fund a shareholder dividend, with GE Capital as lead bank for the deal.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics